| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,591 |
2,205 |
$170K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34,163 |
15,870 |
$154K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
611 |
564 |
$80K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,125 |
2,713 |
$77K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,070 |
12,780 |
$73K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,221 |
4,516 |
$64K |
| 99215 |
Prolong outpt/office vis |
7,306 |
3,695 |
$49K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,945 |
3,381 |
$49K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,756 |
1,189 |
$43K |
| 70450 |
Computed tomography, head or brain; without contrast material |
460 |
415 |
$36K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,418 |
2,420 |
$34K |
| 80053 |
Comprehensive metabolic panel |
10,839 |
9,295 |
$28K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,724 |
1,364 |
$16K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,299 |
1,196 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
1,028 |
949 |
$16K |
| 90837 |
Psychotherapy, 53 minutes with patient |
4,847 |
2,243 |
$16K |
| 71045 |
Radiologic examination, chest; single view |
936 |
825 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,419 |
1,896 |
$14K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,278 |
1,163 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,875 |
1,617 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,348 |
8,354 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,575 |
4,408 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,761 |
3,625 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,784 |
2,276 |
$6K |
| Q3014 |
Telehealth originating site facility fee |
5,338 |
3,731 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
928 |
458 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,223 |
596 |
$4K |
| 97162 |
|
421 |
392 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
496 |
365 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
31 |
29 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
13,147 |
11,235 |
$4K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
708 |
607 |
$3K |
| 98929 |
|
597 |
250 |
$3K |
| 82607 |
|
1,010 |
979 |
$3K |
| 84484 |
|
1,709 |
1,380 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
290 |
276 |
$3K |
| 83735 |
|
3,541 |
2,558 |
$3K |
| G0378 |
Hospital observation service, per hour |
17 |
15 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,427 |
738 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,522 |
1,022 |
$2K |
| 80061 |
Lipid panel |
3,084 |
2,993 |
$2K |
| 97161 |
|
291 |
278 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
909 |
879 |
$2K |
| 81001 |
|
2,193 |
1,830 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
22 |
12 |
$2K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
433 |
402 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,645 |
3,191 |
$1K |
| 85027 |
|
2,266 |
2,117 |
$1K |
| 82728 |
|
829 |
774 |
$1K |
| 80306 |
|
1,852 |
1,645 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,284 |
1,163 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,661 |
1,500 |
$1K |
| 86140 |
|
1,059 |
933 |
$1K |
| 85610 |
|
2,234 |
1,408 |
$1K |
| 85652 |
|
1,022 |
919 |
$1K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
347 |
341 |
$1K |
| 99350 |
Prolong home eval add 15m |
52 |
51 |
$989.83 |
| 83540 |
|
808 |
755 |
$876.80 |
| 90834 |
Psychotherapy, 45 minutes with patient |
962 |
608 |
$868.37 |
| 83880 |
|
181 |
157 |
$864.68 |
| 97035 |
|
261 |
124 |
$846.27 |
| 82043 |
|
369 |
355 |
$819.51 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,457 |
1,334 |
$805.91 |
| 83690 |
|
1,414 |
1,255 |
$780.63 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
4,241 |
3,656 |
$754.63 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,937 |
3,794 |
$727.24 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
620 |
393 |
$702.76 |
| 90715 |
|
444 |
428 |
$700.65 |
| 83550 |
|
637 |
602 |
$682.13 |
| 99443 |
|
44 |
40 |
$548.13 |
| 87631 |
|
628 |
590 |
$544.96 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
763 |
597 |
$537.02 |
| G0008 |
Administration of influenza virus vaccine |
1,244 |
1,216 |
$521.89 |
| 84439 |
|
343 |
323 |
$520.34 |
| 86618 |
|
528 |
509 |
$515.03 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
918 |
796 |
$498.25 |
| 73610 |
|
27 |
26 |
$493.47 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
294 |
251 |
$483.05 |
| 94760 |
|
427 |
348 |
$431.23 |
| 82570 |
|
241 |
228 |
$421.63 |
| 81003 |
|
1,280 |
1,195 |
$419.15 |
| 87077 |
|
604 |
560 |
$412.43 |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,092 |
737 |
$362.80 |
| 90662 |
|
417 |
407 |
$342.94 |
| 96127 |
|
291 |
250 |
$329.50 |
| 99442 |
|
36 |
34 |
$313.06 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
123 |
121 |
$226.71 |
| 91320 |
|
173 |
170 |
$225.74 |
| 98927 |
|
26 |
12 |
$214.52 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
22 |
16 |
$203.20 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,842 |
3,271 |
$188.03 |
| 81002 |
|
387 |
364 |
$182.21 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
186 |
113 |
$162.45 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
32 |
30 |
$147.17 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,497 |
732 |
$131.01 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
741 |
731 |
$128.45 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
69 |
63 |
$109.59 |
| 87468 |
|
109 |
106 |
$109.45 |
| 0011A |
|
779 |
768 |
$106.00 |
| 0124A |
|
277 |
270 |
$100.75 |
| 87186 |
|
69 |
66 |
$98.93 |
| 0012A |
|
883 |
847 |
$96.79 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
228 |
199 |
$92.60 |
| 87469 |
|
109 |
106 |
$90.12 |
| 87484 |
|
109 |
106 |
$90.12 |
| 90686 |
|
1,366 |
1,336 |
$87.06 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
795 |
763 |
$74.83 |
| 98928 |
|
30 |
12 |
$72.25 |
| 0064A |
|
463 |
446 |
$66.56 |
| 90480 |
|
222 |
219 |
$58.99 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
14 |
13 |
$56.91 |
| 87478 |
|
67 |
65 |
$53.91 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
24 |
21 |
$52.18 |
| 81025 |
|
792 |
738 |
$49.71 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
708 |
688 |
$48.08 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
625 |
616 |
$47.84 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
708 |
689 |
$46.68 |
| 82948 |
|
46 |
12 |
$38.18 |
| 99406 |
|
73 |
69 |
$34.74 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
280 |
265 |
$34.05 |
| A9270 |
Non-covered item or service |
33 |
30 |
$33.26 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
53 |
43 |
$32.73 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,308 |
1,286 |
$30.11 |
| 90670 |
|
40 |
40 |
$18.71 |
| 86038 |
|
12 |
12 |
$18.26 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
33 |
28 |
$16.99 |
| 83605 |
|
103 |
77 |
$16.51 |
| J2704 |
Injection, propofol, 10 mg |
15 |
13 |
$16.04 |
| 0054A |
|
26 |
26 |
$13.62 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
19 |
15 |
$13.61 |
| 85379 |
|
15 |
13 |
$13.54 |
| 0003A |
|
54 |
54 |
$10.53 |
| 82565 |
|
14 |
13 |
$8.46 |
| 90658 |
|
15 |
15 |
$7.61 |
| 85014 |
|
34 |
26 |
$7.48 |
| 81015 |
|
17 |
15 |
$7.14 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
12 |
12 |
$3.94 |
| 87040 |
|
13 |
12 |
$2.44 |
| 87205 |
|
13 |
12 |
$0.22 |
| 82947 |
|
14 |
13 |
$0.14 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
985 |
493 |
$0.00 |
| 90734 |
|
36 |
36 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
777 |
395 |
$0.00 |
| 0002A |
|
116 |
114 |
$0.00 |
| 90685 |
|
331 |
328 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
648 |
321 |
$0.00 |
| 91312 |
|
209 |
204 |
$0.00 |
| 90713 |
|
42 |
42 |
$0.00 |
| 90707 |
|
27 |
27 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
524 |
262 |
$0.00 |
| 91300 |
|
744 |
447 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
124 |
123 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
222 |
109 |
$0.00 |
| 90633 |
|
25 |
25 |
$0.00 |
| 91322 |
|
44 |
44 |
$0.00 |
| 80076 |
|
13 |
12 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
13 |
13 |
$0.00 |
| 0004A |
|
175 |
172 |
$0.00 |
| 0071A |
|
82 |
82 |
$0.00 |
| 90710 |
|
12 |
12 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
72 |
67 |
$0.00 |
| 0013A |
|
12 |
12 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
27 |
14 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
13 |
13 |
$0.00 |
| 0001A |
|
153 |
148 |
$0.00 |
| 87081 |
|
273 |
267 |
$0.00 |
| 91307 |
|
68 |
68 |
$0.00 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
15 |
15 |
$0.00 |
| 85651 |
|
14 |
12 |
$0.00 |
| 91305 |
|
103 |
99 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
27 |
27 |
$0.00 |
| 91301 |
|
1,015 |
929 |
$0.00 |
| 91306 |
|
63 |
63 |
$0.00 |
| 0072A |
|
93 |
93 |
$0.00 |
| 0154A |
|
12 |
12 |
$0.00 |
| 0031A |
|
32 |
30 |
$0.00 |
| 90716 |
|
26 |
26 |
$0.00 |
| 90656 |
|
13 |
13 |
$0.00 |
| 90619 |
|
19 |
19 |
$0.00 |
| 91315 |
|
13 |
13 |
$0.00 |